Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Research & Development (2009 - 2026)

Updated

Bristol Myers Squibb (BMY) recorded Research & Development of $2.37 billion in Q3 2026, down 6.4% from $2.53 billion a year earlier and down 20.1% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Research & Development (2009 - 2026) Analysis & Trends

On a TTM basis, Bristol Myers Squibb's Research & Development came in at $10.56 billion as of Sep 30, 2026, unchanged year-over-year; for FY2025, it was $9.95 billion, down 10.8% from FY2024.

  • Annual Research & Development has a five-year compound annual growth rate of -0.2% (FY2020 to FY2025).
  • Across earlier years, Research & Development came in at $11.16 billion in FY2024 (+20.0%), $9.3 billion in FY2023 (-2.2%), $9.51 billion in FY2022 (-6.7%) and $10.2 billion in FY2021 (+1.5%).
  • The Q3 2026 figure is the lowest quarterly Research & Development since Q1 2025.
  • On a year-over-year basis, Research & Development rose in four of the last eight quarters, with growth averaging 1.8%.
  • Peak year-over-year performance for Research & Development in the last five years was growth of 28.8% in Q4 2024, against a decline of 19.0% in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $2.96 billion (Q2 2026), $2.65 billion (Q1 2026) and $2.59 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 4.25 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 4.65 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 2.57 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 4.54 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 3.89 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 2.11 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 1.61 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 3.02 Bn
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn 2.37 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 2.37 Bn
Jun 30, 2026 2.96 Bn
Mar 31, 2026 2.65 Bn
Dec 31, 2025 2.59 Bn
Sep 30, 2025 2.53 Bn
Jun 30, 2025 2.58 Bn
Mar 31, 2025 2.26 Bn
Dec 31, 2024 3.19 Bn
Sep 30, 2024 2.37 Bn
Jun 30, 2024 2.90 Bn
Mar 31, 2024 2.70 Bn
Dec 31, 2023 2.48 Bn
Sep 30, 2023 2.24 Bn
Jun 30, 2023 2.26 Bn
Mar 31, 2023 2.32 Bn
Dec 31, 2022 2.51 Bn
Sep 30, 2022 2.42 Bn
Jun 30, 2022 2.32 Bn
Mar 31, 2022 2.26 Bn
Dec 31, 2021 2.52 Bn
API Access

Bristol Myers Squibb Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=BMY&period=max&api_key=YOUR_API_KEY